Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer [PDF]
Chen, Ina, et al,
core +2 more sources
Janus Kinase Inhibitors as A Breakthrough Treatment for Refractory Dissecting Cellulitis of the Scalp. [PDF]
Al-Mamoori A +3 more
europepmc +1 more source
A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis. [PDF]
Chay T +6 more
europepmc +1 more source
Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in VigiBase. [PDF]
Abolhassani N +7 more
europepmc +1 more source
Janus kinase inhibitors - a role for the treatment of cutaneous T-cell lymphomas? [PDF]
Packer SE, Brunner PM.
europepmc +1 more source
Revisiting Janus Kinase Inhibitors in Hospitalized COVID-19: Evidence for Baricitinib's Superiority and the Absence of a Class Effect. [PDF]
Gu L, Lin J, Yue J, Liu Z, Huang JA.
europepmc +1 more source
Adverse effects of Janus kinase inhibitors with relevance for daily practice in dermatology. [PDF]
Rajput Khokhar A, Ghoreschi K, Huynh J.
europepmc +1 more source
Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort. [PDF]
Nathan J +21 more
europepmc +1 more source
AKT/eNOS signaling module functions as a potential feedback loop in the growth hormone signaling pathway [PDF]
Cong-Jun Li +2 more
core +1 more source
Janus kinase inhibitors in localized scleroderma: a systematic literature review. [PDF]
Şener S +4 more
europepmc +1 more source

